Skip to main content
. 2024 May 27;10:37. doi: 10.1038/s41523-024-00644-4

Fig. 1. Study design.

Fig. 1

Schematic representation of the ARTEMIS clinical trial showing PDX models established at clinical presentation (Pre), after four cycles of Adriamycin and cyclophosphamide (AC, Mid), and after completion of NACT (Post). Patient IDs (PiD) and Patient in Mouse (PIM) IDs that were established at each time point are shown below. Color code denotes matched patient/PDX serial models.